Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-040 - Clinical Utility of Plasma-Based NGS for Advanced-Stage NSCLC Patients with Insufficient or Unavailable Tumor Tissue
09:30 - 09:30 | Presenter: Pilar Garrido | Author(s): J. Zugazagoitia, A. Gómez Rueda, S. Ponce, I. Ramos, C. Camps, D. Isla, Ó. Juan, Rosario García Campelo, J. De Castro, M. Trigo, E. Jantus-Lewintre, M. Palka, Luis Paz-Ares
- Abstract
Loading...
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.02 - Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC
11:05 - 11:10 | Presenter: Luis Paz-Ares | Author(s): B.P. Levy, Giuseppe Giaccone, Benjamin Besse, Enriqueta Felip, Marina Chiara Garassino, M. Domine, Pilar Garrido, B. Piperdi, S. Ponce Aix, R. Slepetis, X. Wu, A. Fandi
- Abstract
Loading...
-
+
MA 03 - Chemotherapy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 502
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Jin-Hyoung Kang, W. Su
-
+
MA 03.01 - Nab-Paclitaxel ± CC-486 as Second-Line Treatment of Advanced NSCLC: Results from the ABOUND.2L+ Study
11:00 - 11:05 | Presenter: Ramaswamy Govindan | Author(s): D. Morgensztern, Manuel Cobo Dols, S. Ponce Aix, Pieter E. Postmus, Jaafar Bennouna, J.R. Fischer, O.J. Vidal, D.J. Stewart, G. Fasola, J. Weaver, M. Wolfsteiner, T.J. Ong
- Abstract
Loading...
-
+
MA 05 - Immuno-Oncology: Novel Biomarker Candidates
- 15:45 - 17:30
- 10/16/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:Yoichi Nakanishi, P. Mitchell
-
+
MA 05.03 - The Early Monitoring of Derived Neutrophil-To Lymphocyte Ratio (dNLR) Could Be a Surrogate Marker of Benefit of Immunotherapy in NSCLC
15:55 - 16:00 | Presenter: Laura Mezquita | Author(s): E. Auclin, M. Charrier, Roberto Ferrara, C. Caramella, David Planchard, S. Ponce, Luis Paz-Ares, C. Audigier-Valette, L. Tessonnier, G. Martinez, G. Zalcman, J. Lahmar, J. Remon, J. Adam, N. Chaput, J. Soria, Benjamin Besse
- Abstract
Loading...
-
+
PL 02 - Presidential Symposium including Top 3 Abstracts and James Cox Lectureship Award Presentation
- 08:15 - 09:45
- 10/17/2017
- Location: Plenary Hall (Exhibit Hall D)
- Type: Plenary Session
- Track: Early Stage NSCLC
- Moderators:Hisao Asamura, Keunchil Park
-
+
PL 02.04 - SCAT Ph III Trial: Adjuvant CT Based on BRCA1 Levels in NSCLC N+ Resected Patients. Final Survival Results a Spanish Lung Cancer Group Trial
08:40 - 08:50 | Presenter: Bartomeu Massuti | Author(s): Manuel Cobo Dols, M. Rodriguez-Paniagua, I. Ballesteros, T. Morán, R. Arrabal, J.L. González-Larriba, I. Barneto, Y.W. Pun, J. De Castro, S. Ponce Aix, C. Baamonde, M.A. Muñoz, G. López-Vivanco, J.J. Rivas De Andrés, D. Isla, R. López, José Miguel Sánchez-Torres, J. Sánchez Paya, Rafael Rosell
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-060 - Response Assessment and Subgroups Analysis According to the Lung Immune Prognostic Index (LIPI) for Immunotherapy in Advanced NSCLC Patients
09:30 - 09:30 | Presenter: Laura Mezquita | Author(s): E. Auclin, Roberto Ferrara, C. Caramella, M. Charrier, J. Remon, David Planchard, S. Ponce, Luis Paz-Ares, J. Lahmar, L. Leroy, C. Audigier-Valette, J. Zeron-Medina, Pilar Garrido, G. Zalcman, Julien Mazieres, J. Adam, N. Chaput, J. Soria, Benjamin Besse
- Abstract
Loading...
-
+
MA 07 - ALK, ROS and HER2
- 15:45 - 17:30
- 10/17/2017
- Location: Room 316
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Robert C. Doebele, J.C. Ho
-
+
MA 07.03 - Incidence, Predictors and Prognostic Significance of Thromboembolic Events in Patients with Advanced Alk-Rearranged NSCLCs
15:55 - 16:00 | Presenter: Jon Zugazagoitia | Author(s): M. Biosca, J.F. Grau, J. Olivera, L. Bei, M.E. Olmedo, A. Gómez Rueda, N. Muñoz, S. Ponce, M. Domine, V. Zenzola, Ernest Nadal, J.C. Ruffinelli, A.M. Luna, B. Hernández, M. Martínez, C. Font, M. García-Morillo, I. Gallego, D. Sánchez Cabrero, J. Miranda, E. Martínez De Castro, J.D. Cacho, V. Calvo, J. Martínez, E. Noguerón, R. Mondéjar, I. García Escobar, C. Salvador-Coloma, Ó. Juan, M. Sánchez Cánovas, J. Valdivia, M..P. Ochoa, R. López Castro, B. Obispo, C. Pangua, M. Sereno, L. Fernández Franco, X. Mielgo, J. Calzas, A. Blasco, F. Aparisi, L. Chara, D. Lora, A.J. Muñoz, Luis Paz-Ares, A. Manzano
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-071 - Randomized Phase 1b/3 Study of Erlotinib + Ramucirumab in Untreated EGFR Mutation-Positive Stage IV NSCLC: Phase 1b Outcomes
09:30 - 09:30 | Presenter: Kazuhiko Nakagawa | Author(s): Edward Brian Garon, Luis Paz-Ares, S. Ponce, J. Corral Jaime, O. Juan Vidal, Ernest Nadal, K. Kiura, Keunchil Park, R.C. Widau, E. Alexandris, S. He, P. Lee, Martin Reck
- Abstract
Loading...